It's
"Certification"
Time
Again:
Mexico
Makes
the
Grade,
Colombia
Doesn't
--
But
Sanctions
Will
Be
Lifted
2/27/98
In the annual, controversial ritual in which the President, with the consent of Congress, certifies those nations which have been appropriately cooperative in the global Drug War, Mexico has maintained its status as an ally, while Colombia, which has been decertified for the past two years, will remain off the list but will see US sanctions lifted. None of this is final, of course, as Congress may well attempt to overturn President Clinton's decisions, as they attempted unsuccessfully to do last year with regard to Mexico. The Associated Press (2/26) reports that there is already a move on in Congress to decertify Mexico legislatively. Nations which have been denied certification face economic sanctions including an automatic "no" vote by the U.S. on any loan requests to the World Bank. That is exactly the position in which Colombia has found itself over the past two years; the Clinton Administration has cited its belief that President Ernesto Samper received over $6 million in campaign contributions from drug traffickers during his 1994 campaign. Clinton's recommendation this year, that Colombia remain decertified but have economic sanctions waived, apparently reflects the belief of the administration that Colombia's police force and new attorney general are relatively free of corruption and are making a good-faith effort to combat the multi-billion dollar trade. The AP notes that US officials acknowledge the massive eradication efforts in Colombia but also know that increased planting of coca has more than made up the difference. to admit is that it doesn't make a difference how hard a source country "fights" the drug trade -- demand for drugs in the US and other countries assures that someone will provide the supply. Study after study, many of them by the government's own General Accounting Office, have found that source country efforts have had negligible long-term impact on the price and availability of drugs in the US.]
|